Fundz

Fundz Deep Dive

Everything you need to win ImmunoPrecise Antibodies (Europe) B.V — in one platform.

Who to reach, what to say, and why now on ImmunoPrecise Antibodies (Europe) B.V — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on ImmunoPrecise Antibodies (Europe) B.V — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus

Oct 02, 2024•over 1 year ago

Contract Type

agreement

VictoriaBiotechnologyTherapeutics

Description

ImmunoPrecise Antibodies Ltd. and Biotheus Inc. have entered into a Material Transfer and Evaluation Agreement (MTEA) concerning a Talem therapeutic antibody asset for the development of a bispecific therapy against solid tumors. Under the agreement, Biotheus will have the rights to further evaluate the suitability of Talem’s AI-enhanced TATX-20 lead candidate for the development of novel bispecific antibodies for the treatment of hypoxic solid tumors.

Company Information

Company

ImmunoPrecise Antibodies (Europe) B.V

Location

Victoria, British Columbia, Canada

About

ImmunoPrecise Antibodies (Europe) B.V. specializes in antibody discovery, engineering, and characterization services. It operates in Europe and has advanced capabilities for recombinant protein expression. The company is a carve-out from ImmunoPrecise Antibodies Ltd.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for ImmunoPrecise Antibodies (Europe) B.V's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.